Assessment of response to induction therapy and its influence on 5-year failure-free survival (FFS) in Group III rhabdomyosarcoma (RMS): Intergroup Rhabdomyosarcoma Study ORSHV experience Meeting Abstract

  

Authors:	Breitfeld, P. P.; Anderson, J.; Kao, S.; Rodeberg, D.; Qualman, S.; Wolden, S.; Meyer, W.
Abstract Title:	Assessment of response to induction therapy and its influence on 5-year failure-free survival (FFS) in Group III rhabdomyosarcoma (RMS): Intergroup Rhabdomyosarcoma Study ORSHV experience
Meeting Title:	40th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	22
Issue:	14 Suppl.
Meeting Dates:	2004 Jun 5-8
Meeting Location:	New Orleans, LA
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2004-07-15
Start Page:	802S
Language:	English
ACCESSION:	WOS:000223512403183
PROVIDER:	wos
Notes:	Meeting Abstract: 8513 -- 40th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LA -- S -- Source: Wos